Riverview Trust CO Repligen Corp Transaction History

Riverview Trust CO

  • $112 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024
BUY
$170.78 - $208.42 $15,370 - $18,757
90 New
90 $16,000
Q2 2023

Jul 17, 2023
BUY
$138.42 - $180.31 $12,457 - $16,227
90 New
90 $12,000
Q2 2022

Jul 27, 2022
SELL
$140.68 - $188.02 $11,676 - $15,605
-83 Closed
0 $0
Q1 2022

Apr 21, 2022
BUY
$161.19 - $257.96 $13,378 - $21,410
83 New
83 $16,000

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.59B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email